Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib plus TACE in advanced HCC
NCT00618384Phase 2Terminated
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Jan 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Heinrich Heine University Düsseldorf. Started Jan 2008; status: terminated.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00618384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00618384.